LithiumBank Resources

LATEST CANNABIS CBD STOCK NEWS


Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the Medical Cannabis by Shoppers Business

Last Trade: 0.28 0.02 9.52

TORONTO, May 29, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce the execution of the definitive Asset Purchase Agreement (“Agreement”) between Shoppers Drug Mart®  (“Shoppers”) and Avicanna for... Read more


CENTR Brands Smarter Energy Line Sees Significant Chain Store Growth Since Launching

Last Trade: 0.22 0.03 17.74

Vancouver, British Columbia--(Newsfile Corp. - May 29, 2023) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) ("CENTR" or the "Company"), a leading manufacturer of better-for-you beverages, is pleased to announce it has experienced significant chain store adoption in key markets for its recently launched CENTR Enhanced functional beverage. CENTR Enhanced+ Caffeine CENTR Enhanced, a better-for-you... Read more


Irwin Naturals Reports Year End 2022 Financial Results and Recent Events

Last Trade: 1.25 0.00 0.00

LOS ANGELES, May 25, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) today reported its financial results for the fourth quarter and year ended December 31, 2022, on www.sedar.com. Financial Highlights for FY 2022 (all comparisons are for the year ended December 31 unless otherwise indicated): Annual revenue was $89.5 million, down 10.8% from $100.3... Read more


Vext Science Announces Financial Results for Q1 2023

Last Trade: 0.21 -0.0041 -1.94

Revenue of $9.1 million, Adjusted EBITDA of $2.9 million, Adjusted EBITDA Margin of 32%. Generated positive EBITDA of $1.6 million. Expanded retail footprint through the acquisition of Jackson, Ohio dispensary and reported solid performance during first quarter under Vext ownership. Previously announced acquisition of vertically integrated Ohio operations on track to close towards the end of Q3 2023 and... Read more


Clever Leaves Partners with SOMAÍ Pharmaceuticals and Sends First Commercial Shipments to Portugal

Last Trade: 0.25 0.0031 1.23

TOCANCIPÁ, Colombia, May 25, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today that it has entered into a five-year agreement with SOMAÍ Pharmaceuticals, to supply its operations in Portugal with EU-GMP certified CBD extracts from Colombia. With the first shipments under the agreement already completed, Clever Leaves will continue to... Read more


Delivra Health Brands Enters into Licence Agreement with Canopy Growth to Manufacture and Distribute its Leading Infused Topical Brand LivRelief(TM)

Last Trade: 0.02 0.0004 2.44

Vancouver, British Columbia--(Newsfile Corp. - May 24, 2023) -  Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) (formerly, Harvest One Cannabis Inc.) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, announced today that its wholly-owed subsidiary, Delivra Inc., has granted a subsidiary of Canopy Growth Corporation... Read more


TerrAscend and Wana Brands Debut Cannabis-Infused Gummies in New Jersey

Last Trade: 1.55 -0.08 -4.91

TORONTO, May 18, 2023 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced the highly anticipated debut of Wana Brands' renowned cannabis-infused gummies in New Jersey. TerrAscend serves as Wana's sole manufacturer, supplier, and commercialization partner in New Jersey and is now offering a diverse range of Wana products... Read more


Skye Bioscience Begins Dosing Fifth of Six Cohorts in Phase 1 Clinical Trial of Novel CB1R Agonist

Last Trade: 0.01 -0.0001 -0.74

Skye advances multiple ascending dose arm of SBI-100 Ophthalmic Emulsion trial San Diego, California--(Newsfile Corp. - May 17, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma and ocular hypertension, has started dosing the second cohort of the multiple ascending dose ("MAD") arm of its... Read more


Avicanna Reports Q1 2023 Financial Statement

Last Trade: 0.28 0.02 9.52

TORONTO, May 16, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased announce the filing of interim financial statements for the three-month period ending March 31, 2023 (“Q1 2023”). Aras Azadian, CEO stated,... Read more


Clever Leaves Granted Brazilian GMP Certification for Cannabis Products by ANVISA

Last Trade: 0.25 0.0031 1.23

Multinational operator has been granted Brazilian GMP certification by ANVISA for the manufacturing of cannabis products Clever Leaves is the first and only medicinal cannabis company globally who has GMP certifications from the EU, Colombia and Brazil TOCANCIPÁ, Colombia, May 16, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today... Read more


Columbia Care Reports First Quarter 2023 Results

Last Trade: 0.44 -0.05 -9.42

Quarterly Revenue of $125 Million, an Increase of 1% YoY Quarterly Gross Profit of Over $47 Million, an Increase of 13% QoQ Quarterly Adjusted EBITDA1 of Over $16 Million and Adjusted EBITDA Margin1 of Over 13% NEW YORK / May 15, 2023 / Business Wire / Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators,... Read more


cbdMD Stabilizes Revenue and Significantly Improves Operating Results

Last Trade: 1.80 -0.03 -1.64

Company reduces annualized SG and A expenses $24 million year over year Charlotte, North Carolina--(Newsfile Corp. - May 15, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator the leading CBD brands - including its flagship brand cbdMD, and its animal health brand Paw CBD, today announced our second... Read more


CV Sciences Reports First Quarter 2023 Financial Results

Last Trade: 0.04 -0.0003 -0.78

SAN DIEGO, May 15, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2023. First Quarter 2023 and Recent Financial and Operating Highlights Generated... Read more


Delta 9 Cannabis Reports First Quarter 2023 Results

Last Trade: 0.04 0.0001 0.22

WINNIPEG, Manitoba, May 15, 2023 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQB: DLTNF) (“Delta 9” or the “Company”), is pleased to announce financial and operating results for the three-month period ending March 31, 2023. Financial Highlights for Q1, 2023: Net revenue of $16.9 million versus $12.5 million for the three-month period ending March 31, 2022, an increase of 35%. Gross profit, before... Read more


Skye Bioscience Receives Positive Safety Review in First Multiple-Administration Cohort of Phase 1 Study of SBI-100 Ophthalmic Emulsion

Last Trade: 0.01 -0.0001 -0.74

San Diego, California--(Newsfile Corp. - May 15, 2023) -  Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reports that the safety review committee ("SRC") for its Phase 1 clinical trial of SBI-100 Ophthalmic Emulsion ("OE") has reviewed the data from the trial's fourth cohort and provided... Read more


Charlotte's Web Holdings Reports 2023 First Quarter Financial Results

Last Trade: 0.22 -0.0009 -0.41

Net cash of $61M Net revenue of $17M decreased 12.1% YoY 14% YoY reduction in operating expenses LOUISVILLE, Colo., May 12, 2023 /CNW/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2023. "In the first quarter, we... Read more


Tilray Brands: Solei Brand Debuts Premium CBD, CBN and THC Infused Tea Collection

Last Trade: 1.86 -0.50 -21.19

TORONTO, May 11, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today premiered a new infused tea collection by cannabis wellness brand, Solei, marking the brand’s first cannabis infused drink line. Solei’s new tea collection is a wellness-based product line of caffeine-free teas produced with... Read more


Clever Leaves Reports First Quarter 2023 Results

Last Trade: 0.25 0.0031 1.23

Continued Commercial Momentum Within Core Cannabinoid Markets  Recent Commercial Launches of Colombian Dry Flower Exports to Australia and Germany Mark Key Operational Milestone  Continuing Cost Reduction Measures Drive Leaner Operational Infrastructure  Reiterating Previously Issued 2023 Outlook  TOCANCIPÁ, Colombia, May 11, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ:... Read more


Willow Biosciences Reports First Quarter 2023 Results

Last Trade: 0.10 0.0019 1.90

Starts off year with significant commercial momentum toward focus on delivering robust year-over-year revenue growth for 2023 Previous steps taken to further optimize Willow's business, focus on near-term revenue generation and reduce cash burn are paying off MOUNTAIN VIEW, Calif., May 11, 2023 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading... Read more


Lexaria Bioscience: cGMP Manufacturing Complete for Lexaria's Upcoming U.S. Phase 1b Hypertension Clinical Trial

Last Trade: 0.78 0.03 4.48

DehydraTECH-CBD is currently unique in its evidenced superior power to reduce blood pressure over other oral CBD formulations. DehydraTECH-CBD has demonstrated exceptional safety and tolerability and a sustained decrease in blood pressure. KELOWNA, BC / ACCESSWIRE / May 11, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms... Read more


Item 9 Labs Releases Latest Limited Edition One-Gram Rosin-Infused Pre-Rolls

Last Trade: 0.04 0.00 0.00

Award-winning cannabis brand meets increasing niche market demand, adds pre-roll to innovative product lineup PHOENIX / May 10, 2023 / Business Wire / Item 9 Labs, an award-winning, premium cannabis brand, announced the latest release of its limited edition one-gram rosin-infused pre-rolls in participating Arizona dispensaries. The product release follows a successful initial test run in December 2022 that... Read more


Cronos Group Reports 2023 First Quarter Results

Last Trade: 1.77 -0.03 -1.67

Industry-leading balance sheet with $836 million in cash and short-term investments Targeting positive cash flow in 2024 Net revenue in Canada increased 6% in Q1 2023 compared to Q1 2022; on a constant currency basis net revenue in Canada increased 14% in Q1 2023 compared to Q1 2022 Spinach® was top-10 in retail sales in the flower, edible, vape and pre-roll categories in Q1 2023 TORONTO, May 09, 2023... Read more


Innocan Pharma Reports Success in a Pre-Clinical Trial of a Liposomal-CBD Injection on a Paralyzed Goat

Last Trade: 0.14 0.00 0.00

HERZLIYA, Israel and CALGARY, Alberta, May 8, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a leading pharmaceutical and biotech company, is pleased to announce the successful treatment of Billy, a 4-year-old neutered male goat, with a liposomal-CBD injection in a pre-clinical trial. The innovative... Read more


Vibe Growth Corporation Showcases its Premium Indoor-Grown Cannabis Infused Pre-Rolls and High Potency Distillate Carts at Hall of Flowers Event

Last Trade: 0.04 0.00 0.00

Vibe debuts its versatile range of products; including infused pre-rolls, indoor-grown cannabis strains, and high-potency distillate carts at the Hall of Flowers trade show in Santa Rosa, California. Santa Rosa, California--(Newsfile Corp. - May 5, 2023) -  Vibe Growth Corporation (CSE: VIBE) (OTCQX: VBSCF) (FSE: A061) (the "Company" or "Vibe"), a leading vertically integrated multi-state cannabis enterprise... Read more


Avicanna and Northern Green Canada Execute Master Service Agreement to Operationalize MyMedi.ca

Last Trade: 0.28 0.02 9.52

MyMedi.ca to provide Medical Cannabis by Shoppers patients a complete medical cannabis care platform including curated products and services. NGC will facilitate inventory management and fulfillment through its EU GMP-certified and Health Canada licensed infrastructure starting Q2, 2023. TORONTO, May 04, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF)... Read more


cbdMD Announces Closing of $2.8 Million Underwritten Public Offering of Common Stock

Last Trade: 1.80 -0.03 -1.64

Charlotte, North Carolina--(Newsfile Corp. - May 3, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading CBD companies, today announced the closing of its previously announced underwritten public offering of 1,350,000 shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering before deducting underwriting discounts and... Read more


LEEF Brands Reports Fourth Quarter and Full Year 2022 Financial Results Along with First Quarter 2023 Financial Results

Last Trade: 0.06 0.00 0.00

Q1 2023 Revenue of $9.7M, up 114% from Q4 2022 Q1 2023 Adjusted EBITDA of $726K, up 175% from Q4 2022 Positive cashflow from operations VANCOUVER, British Columbia, May 02, 2023 (GLOBE NEWSWIRE) -- LEEF Brands, Inc. (CSE: LEEF, OTC: LEEEF) ("LEEF" or the "Company"), a leading cannabis brand operator, announced today the release of its audited financial statements for the year ended 2022 along with the... Read more


CLS Holdings USA: Oasis Cannabis Dispensary Welcomes The Real McCoy

Last Trade: 0.05 0.00 0.00

LAS VEGAS, NV / ACCESSWIRE / May 2, 2023 / CLS Holdings USA Inc., and Oasis Cannabis Dispensary are pleased to welcome The Real McCoy to our Dispensary shelves. The Real McCoy is a boutique cannabis company located in Nevada that prides themselves on producing the purest indoor grown cannabis. Oasis Cannabis Dispensary is proud to be carrying The Real McCoy's small batch, high quality hand crafted flower, which... Read more


Irwin Naturals: Update on Release of the 2022 Year End Financials and Board Of Directors

Last Trade: 1.25 0.00 0.00

LOS ANGELES, May 02, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announces that the British Columbia Securities Commission has issued a failure-to-file-cease trade order (“CTO”) pursuant to National Policy 11-207 – Failure to File Cease Trade Orders and Revocations in Multiple Jurisdictions in respect of the securities of the Company as a result... Read more


Entourage Health Reports Fiscal Year 2022 Financial Results and Posts $54.5 Million in Total Revenues

Last Trade: 0.01 -0.0037 -20.56

Record net medical revenue of $17.4 million for 2022, representing 16% growth Entourage secured a 5% share of total sales, ranking them in the fourth spot of national pre-roll sales in 2022 Upsized credit facility with LiUNA Pension Fund Central and Eastern Canada (“LPF”) improves liquidity position TORONTO, May 01, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE)... Read more


Innocan Pharma Announces 5000 Units Sale and Expansion to Lithuania, Latvia & Estonia Markets

Last Trade: 0.14 0.00 0.00

HERZLIYA, Israel and CALGARY, AB, May 1, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the entering into of a wide-scope commercial distribution agreement with UAB Medexy ("UAB Medexy") (the "Distribution Agreement"). As part of the multi-year Distribution Agreement, UAB Medexy has an exclusive right to distribute both of... Read more


Charlotte's Web Holdings Expands Distribution with America's Largest National Distributor in Pet Specialty, Phillips Pet Food & Supplies

Last Trade: 0.22 -0.0009 -0.41

LOUISVILLE, Colo., May 1, 2023 /CNW/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in cannabidiol ("CBD") hemp extract wellness products is pleased to add Phillips Pet Food & Supplies ("Phillips"), America's largest distributor in the pet specialty retail channel, covering more than 6,000 retailers representing more than 14,000 retail... Read more


cbdMD Announces Pricing of $2.8 Million Underwritten Public Offering of Common Stock

Last Trade: 1.80 -0.03 -1.64

Charlotte, North Carolina--(Newsfile Corp. - April 30, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading CBD companies, today announced the pricing of its previously announced underwritten public offering of 1,350,000 shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering are expected to be approximately $2.8 million... Read more


Delta 9 Cannabis Awarded Grow Pod Contract for Cultivation Facility in Alabama

Last Trade: 0.04 0.0001 0.22

WINNIPEG, Manitoba, April 28, 2023 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX:DN) (OTCQX:DLTNF) (“Delta 9” or the “Company”) is pleased to announce that it has secured a purchase order from a United States based customer (the “Customer”) for up to 8 of its modular Grow Pods for an integrated pre-licensed cultivation and processing facility in Alabama. The Customer has also entered into a Strategic Cooperation... Read more


Aurora Cannabis Expands Medical Cannabis Portfolio in Germany: New flower varieties for patients with high THC needs

Last Trade: 0.54 -0.02 -3.55

EDMONTON, AB, April 28, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and a leading manufacturer and supplier of dried flower for medical patients worldwide, today announced the expansion of its portfolio in Germany with the launch of two new cannabis flower products for patients. Pedanios 27/1 FRG CA and Pedanios 29/1 SRD... Read more


cbdMD Announces Proposed Public Offering of Common Stock

Last Trade: 1.80 -0.03 -1.64

Charlotte, North Carolina--(Newsfile Corp. - April 28, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading CBD companies, today announced it has commenced an underwritten public offering of shares of its common stock. All shares of common stock in the offering are to be sold by cbdMD. In addition, cbdMD intends to grant the underwriter in the offering a 45-day option to... Read more


Skye Bioscience Begins Dosing Phase 1 Fourth Cohort in Clinical Trial of Novel CB1R Agonist

Last Trade: 0.01 -0.0001 -0.74

Skye progresses to multiple ascending dose arm of SBI-100 Ophthalmic Emulsion trial after completing single ascending dose arm P1 dosing of novel cannabinoid derivative planned for completion in Q2, with data reporting in Q3 San Diego, California--(Newsfile Corp. - April 27, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic... Read more


CBD of Denver Announces Q4 Revenue of $113,478 Vs. $26,907 for Q3 of 2022

Last Trade: 0.0003 0.00 0.00

Denver, Colorado--(Newsfile Corp. - April 25, 2023) - CBD of Denver Inc (OTC Pink: CBDD), having begun a restructuring of its operations in fourth quarter of 2022, today announced that that revenue increased to $113,478 during the quarter from $26, 907 in the previous quarter putting the Company back on a growth trajectory that management expects to continue throughout 2023 as the Company continues to add new... Read more


Delta 9 Cannabis to Supply Cannabis to Yukon Territory

Last Trade: 0.04 0.0001 0.22

WINNIPEG, Manitoba, April 25, 2023 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”), is pleased to announce that it has entered into an agreement with Yukon Liquor Corporation (“YLC”) to supply recreational use cannabis products to YLC for sale in Yukon Territory. “This marks our seventh Canadian provincial and territorial supply agreement after Manitoba,... Read more


Cronos Group Releases Cannabinoid Life Cycle Study Highlighting its Sustainable Fermentation Practices

Last Trade: 1.77 -0.03 -1.67

TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today, in honor of Earth Day, released a Sustainability Study, which outlines the benefits of using fermentation manufacturing methods for cannabinoid production over the impact of traditional methods of cannabis extraction, which leverage indoor cultivation methods*. The third-party reviewed... Read more

COPYRIGHT ©2022 GREEN STOCK NEWS